Gnao1 (GαO protein) is a likely genetic contributor to variation in physical dependence on opioids in mice

Neuroscience

Volumn 162, Issue 4, 2009, Pages 1255-1264

  Kest, B ^a,b   Smith, S B ^c   Schorscher Petcu, A ^c   Austin, J S ^c   Ritchie, J ^c   Klein, G ^b   Rossi, G C ^d   Fortin, A ^e   Mogil, J S ^c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d LONG ISLAND UNIVERSITY   (United States)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

dependence; G protein; gene mapping; heroin; morphine

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DIAMORPHINE; GENOMIC DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA O SUBUNIT; MORPHINE; NALOXONE; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 8; CONTROLLED STUDY; GENE LOCATION; GENETIC VARIABILITY; HAPLOTYPE; HEROIN DEPENDENCE; JUMPING; LOCUS CERULEUS; MALE; MORPHINE ADDICTION; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; OPIATE ADDICTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE TRAIT LOCUS MAPPING; RECOMBINANT CONGENIC STRAIN; STRAIN DIFFERENCE; WITHDRAWAL SYNDROME; ANIMAL; BIOSYNTHESIS; CHROMOSOME; CONGENIC STRAIN; CROSS BREEDING; GENE SILENCING; GENETICS; METABOLISM; PATHOPHYSIOLOGY; QUANTITATIVE TRAIT LOCUS; SPECIES DIFFERENCE;

ANIMALS; CHROMOSOMES, MAMMALIAN; CROSSES, GENETIC; GENE KNOCKDOWN TECHNIQUES; GENETIC VARIATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HEROIN DEPENDENCE; LOCUS COERULEUS; MALE; MICE; MICE, CONGENIC; MORPHINE DEPENDENCE; NALOXONE; OLIGONUCLEOTIDES, ANTISENSE; QUANTITATIVE TRAIT LOCI; SPECIES SPECIFICITY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 67949104945     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.05.027     Document Type: Article

References (53)

1. Aghajanian G.K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276 (1978) 186-188
2. Bale T.L., and Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44 (2004) 525-557
3. Bao G., Kang L., Li H., Li Y., Pu L., Xia P., Ma L., and Pei G. Morphine and heroin differentially modulate in vivo hippocampal LTP in opiate-dependent rat. Neuropsychopharmacology 32 (2007) 1738-1749
4. Bohn L.M., Xu F., Gainetdinov R.R., and Caron M.G. Potentiated opioid analgesia in norepinephrine transporter knock-out mice. J Neurosci 20 (2000) 9040-9045
5. Broman K.W., Wu H., Sen S., and Churchill G.A. R/qtl: QTL mapping in experimental crosses. Bioinformatics 19 (2003) 889-890
6. Christie M.J., Williams J.T., Osborne P.B., and Bellchambers C.E. Where is the locus in opioid withdrawal?. Trends Pharmacol Sci 18 (1997) 134-140
7. Chu L.F., Liang D.Y., Li X., Sahbaie P., D'arcy N., Liao G., Peltz G., and Clark D.J. From mouse to man: the 5HT3 receptor modulates physical dependence on opioid narcotics. Pharmacogenet Genom 19 (2009) 193-205
8. Duman R.S., Tallman J.F., and Nestler E.J. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J Pharmacol Exp Ther 246 (1988) 1033-1039
9. El-Kadi A.O., and Sharif S.I. The influence of various experimental conditions on the expression of naloxone-induced withdrawal symptoms in mice. Gen Pharmacol 25 (1994) 1505-1510
10. Fábián G., Bozó B., Szikszay M., Horváth G., Coscia C.J., and Szücs M. Chronic morphine-induced changes in mu-opioid receptors and G proteins of different subcellular loci in rat brain. J Pharmacol Exp Ther 302 (2002) 774-780
11. Fortin A., Diez E., Rochefort D., Laroche L., Malo D., Rouleau G.A., Gros P., and Skamene E. Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics 74 (2001) 21-35
12. Franklin K.B.J., and Paxinos G. The mouse brain in stereotaxic coordinates (2007), Academic Press, New York
13. Gelernter J., Panhuysen C., Wilcox M., Hesselbrock V., Rounsaville B., Poling J., Weiss R., Sonne S., Zhao H., Farrer L., and Kranzler H.R. Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet 78 (2006) 759-769
14. Grammatopoulos D.K., and Chrousos G.P. Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 13 (2002) 436-444
15. Haley T.J., and McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 12 (1957) 12-15
16. Hegmann J.P., and Possidente B. Estimating genetic correlations from inbred strains. Behav Genet 11 (1981) 103-114
17. Hoffmann O., Plesan A., and Wiesenfeld-Hallin Z. Genetic differences in morphine sensitivity, tolerance and withdrawal in rats. Brain Res 806 (1998) 232-237
18. Ikeda K., Ide S., Han W., Hayashida M., Uhl G.R., and Sora I. How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol Sci 26 (2005) 311-317
19. Ivanov A., and Aston-Jones G. Local opiate withdrawal in locus coeruleus neurons in vitro. J Neurophysiol 85 (2001) 2388-2397
20. Jiang M., Gold M.S., Boulay G., Spicher K., Peyton M., Brabet P., Srinivasan Y., Rudolph U., Ellison G., and Birnbaumer L. Multiple neurological abnormalities in mice deficient in the G protein go. Proc Natl Acad Sci U S A 95 (1998) 3269-3274
21. i/o-coupled receptors?. Life Sci 73 (2003) 2913-2925
22. Kest B., McLemore G., Kao B., and Inturrisi C.E. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids. J Pharmacol Exp Ther 283 (1997) 1249-1255
23. Kest B., Palmese C.A., Hopkins E., Adler M., and Juni A. Assessment of acute and chronic morphine dependence in male and female mice. Pharmacol Biochem Behav 70 (2001) 149-156
24. Kest B., Palmese C.A., Hopkins E., Adler M., Juni A., and Mogil J.S. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 115 (2002) 463-469
25. Kest B., Palmese C.A., Juni A., Chesler E.J., and Mogil J.S. Mapping of a quantitative trait locus for morphine withdrawal severity. Mamm Genome 15 (2004) 610-617
26. Klein G., Juni A., Arout C.A., Waxman A.R., Inturrisi C.E., and Kest B. Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors. Eur J Pharmacol 586 (2008) 179-188
27. Klein G., Juni A., Waxman A.R., Arout C.A., Inturrisi C.E., and Kest B. A survey of acute and chronic heroin dependence in ten inbred mouse strains: evidence of genetic correlation with morphine dependence. Pharmacol Biochem Behav 90 (2008) 447-452
28. Kogan J.H., Nestler E.J., and Aghajanian G.K. Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur J Pharmacol 211 (1992) 47-53
29. Koob G.F., Maldonado R., and Stinus L. Neural substrates of opiate withdrawal. Trends Neurosci 15 (1992) 186-191
30. Kreek M.J., Bart G., Lilly C., LaForge K.S., and Nielsen D.A. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev 57 (2005) 1-26
31. Lander E.S., and Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11 (1995) 241-247
32. Liang D.Y., Guo T., Liao G., Kingery W.S., Peltz G., and Clark J.D. Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence. Pain 121 (2006) 232-240
33. Maldonado R., and Koob G.F. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res 605 (1993) 128-138
34. Matsuoka I., Maldonado R., Defer N., Noël F., Hanoune J., and Roques B.P. Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur J Pharmacol 268 (1994) 215-221
35. Metten P., Crabbe J.C., and Belknap J.K. Genetic correlates of morphine withdrawal in 14 inbred mouse strains. Drug Alcohol Depend 99 (2009) 123-131
36. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2 (2001) 119-128
37. Nestler E.J., and Aghajanian G.K. Molecular and cellular basis of addiction. Science 278 (1997) 58-63
38. Nestler E.J., and Tallman J.F. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol Pharmacol 33 (1988) 127-132
39. Nestler E.J., Erdos J.J., Terwilliger R., Duman R.S., and Tallman J.F. Regulation of G proteins by chronic morphine in the rat locus coeruleus. Brain Res 476 (1989) 230-239
40. Nestler E.J., Alreja M., and Aghajanian G.K. Molecular control of locus coeruleus neurotransmission. Biol Psychiatry 46 (1999) 1131-1139
41. Rasmussen K., Beitner-Johnson D.B., Krystal J.H., Aghajanian G.K., and Nestler E.J. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci 10 (1990) 2308-2217
42. Reyes B.A., Glaser J.D., and Van Bockstaele E.J. Ultrastructural evidence for co-localization of corticotropin-releasing factor receptor and mu-opioid receptor in the rat nucleus locus coeruleus. Neurosci Lett 413 (2007) 216-221
43. Rossi G.C., Standifer K.M., and Pasternak G.W. Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci Lett 198 (1995) 99-102
44. Rossi G.C., Brown G.P., Leventhal L., Yang K., and Pasternak G.W. Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia. Neurosci Lett 216 (1996) 1-4
45. Sánchez-Blázquez P., and Garzón J. Antibodies directed against alpha subunits of Gi, Gx/z, GO and GS transducer proteins reduced the morphine withdrawal syndrome in mice. Life Sci 55 (1994) L445-L450
46. Selley D.E., Cao C.C., Sexton T., Schwegel J.A., Martin T.J., and Childers S.R. μ Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine. Biochem Pharmacol 62 (2001) 447-455
47. Sharma S.K., Klee W.A., and Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci U S A 72 (1975) 3092-3096
48. Smits S.E. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine. Res Commun Chem Pathol Pharmacol 10 (1975) 651-661
49. Sokal R.R., and Rohlf F.J. Biometry (1981), W. H. Freeman, San Francisco
50. Standifer K.M., Rossi G.C., and Pasternak G.W. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits. Mol Pharmacol 50 (1996) 293-298
51. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., and Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548 (1991) 100-110
52. Valenzuela D., Han X., Mende U., Fankhauser C., Mashimo H., Huang P., Pfeffer J., Neer E.J., and Fishman M.C. G alpha(o) is necessary for muscarinic regulation of Ca2{thorn} channels in mouse heart. Proc Natl Acad Sci U S A 94 (1997) 1727-1732
53. Xu G.P., Van Bockstaele E., Reyes B., Bethea T., and Valentino R.J. Chronic morphine sensitizes the brain norepinephrine system to corticotropin-releasing factor and stress. J Neurosci 24 (2004) 8193-8197